UROGEN PHARMA LTD
URGN·M96088105·US·Common Stock·Healthcare - Biotechnology-Activist
URGN (UROGEN PHARMA LTD) is held by 113 institutional investors as of Q2 2026. Largest holders: RTW INVESTMENTS, LP ($167.2M), BlackRock, Inc. ($117.8M), MORGAN STANLEY ($94.8M). Net institutional sentiment: Mixed.
113
Holders
(9 Elite)
$1B
Total Value
66% (104)
Consensus
69 buying - 35 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 12, 2026 · Insiders Oct 9, 2026 · Activists Aug 12, 2026 · Congress none
InsiderDCDegnan ChrisExercise 4K shOct 8, 2026
InsiderDCDegnan ChrisSell $81KOct 8, 2026
InsiderSDSmith Jason DrewSell $65KSep 8, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 120
1 / 6
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer